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Objective. To understand older primary care patients’ perceptions of the risks and benefits of dementia screening and to measure
the association between attitudes and screening behaviors. Methods. Eligible patients completed the Perceptions Regarding
Investigational Screening for Memory in Primary Care (PRISM-PC) questionnaire and then were asked to undergo dementia
screening by a telephone screening instrument. Results. Higher scores on the PRISM-PC questionnaire items that measure attitudes
about benefits of screening were associated with decreased odds of refusing screening. Participants who refused screening had
significantly lower PRISM-PC questionnaire scores on the items that measure perceived benefits compared to those who agreed to
screening. Participants who refused screening were less likely to agree on screening for other conditions, such as depression and
cancer. Participants who know someone with Alzheimer’s disease (AD) were less likely to refuse screening. Discussion. Patients’
attitudes about the benefits of dementia screening are associated with their acceptance of dementia screening.
1. Introduction
It is estimated that by 2050 there will be 11 to 19million people
in the United States of America (USA) living with dementia
[1]. The incidence of dementia is also growing globally with a
new patient being diagnosed approximately every 7 seconds
[2]. Although there is currently no cure or proven prevention
strategies for dementia, pharmacological and nonpharma-
cological interventions are available that may impact the
symptoms of dementia [3, 4].
Despite rising incidence rates,many patientswith demen-
tia go unrecognized and never receive a cognitive evaluation
or diagnosis. Estimates of undiagnosed dementia among
older adults in the USA range from 45% to 80% [3, 5–7]. In
2013 the United States Preventive Services Task Force (USP-
STF) concluded that the evidence to routinely screen for
dementia in primary care is insufficient due to a lack of studies
evaluating the risks, benefits, and patient perspectives of
the value of dementia screening [8]. Understanding patients’
attitudes about the risks and benefits of early identification
of dementia is vital to assess the value of population-based
dementia screening. In addition, this information allows for a
better understanding of potential barriers and facilitators in
the implementation of dementia screening programs in
primary care settings [9].
The Perceptions Regarding Investigational Screening for
Memory in Primary Care (PRISM-PC) questionnaire was
developed by researchers at the Indiana University Center for
Aging Research to identify the attitudes of older adults
regarding screening for dementia in primary care. The pur-
pose of this study is to understand primary care patients’ per-
ceptions of the risks and benefits of screening and early iden-
tification of dementia and tomeasure the association between
patients’ attitudes and behaviors of screening [10]. Based on
our previous work, we hypothesized that many patients
would report perceived benefits of early identification of
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dementia and that patient’s acceptance of screening would be
associated with the belief that early identification improves
the patient-centered outcomes of the disease. Conversely, we
hypothesized that refusal to be screened would be associated
with the fear that early detection would result in being
stigmatized or the loss of independence.
2. Methods
2.1. Study Population. Eligible patients were 65 years and
older, had no diagnosis of dementia, had seen their primary
care physician within the previous 12 months, and received
their primary care at either St. Vincent Health or Community
Health Network, both of which are located in Indianapolis,
IN. Patients were excluded if they did not speak English, had
hearing loss that precluded them from communicating via
telephone, and had severe mental illness indicated in their
medical record. This study was approved by the Institutional
Review Boards of St. Vincent Hospital and the Community
Health Network.
The research team obtained a list of eligible patients
from the St. Vincent Health and Community Heath primary
care office staff and appointment scheduling records. Eligible
patients at the two sites were approached by telephone and
offered the opportunity to participate in the study by research
assistants from the Indiana University Center for Aging
Research. All recruitment procedures complied with the
Health Insurance Portability and Accountability Act and
Institutional Review Board regulations. Informed consent
was obtained from all patients who agreed to participate in
the study.
2.2. Study Procedures and Instruments. The study uses The
Perceptions Regarding Investigational Screening forMemory
in Primary Care (PRISM-PC) questionnaire to measure
patient’s attitudes and perceived harms and benefits of screen-
ing for dementia. The PRISM-PC questionnaire includes 50
items with 12 items of capturing self-reported sociodemo-
graphic data and information regarding a participant’s expe-
rience with or exposure to Alzheimer’s disease and 38 items
measuring the participant’s perceptions of the acceptability,
harms, and benefits of dementia screening. The PRISM-PC
questionnaire uses the term Alzheimer’s disease as a sub-
stitute for dementia since previous studies have shown that
patients aremore familiar with the term “Alzheimer’s disease”
than “dementia.” Each item of the questionnaire is scored on
a 1- to 5-point Likert scale with possible responses of strongly
agree, agree, do not know, disagree, and strongly disagree
for the following domains: benefits of dementia screening
(8 items), stigma of dementia screening (10 items), negative
effect of dementia screening on independence (6 items),
suffering related to dementia screening (4 items), perceived
acceptance of different types of dementia screening (6 items),
perceived acceptance of screening for other conditions—
colon cancer and depression (2 items), and the belief that a
treatment for Alzheimer’s disease is not currently available (2
items) [10].
IU-PBRN research assistants approached eligible indi-
viduals via telephone and explained the study. After obtain-
ing consent, research assistant administered the PRISM-PC
questionnaire and asked participants to undergo dementia
screening. If participants agreed to screening, it was con-
ducted during the same phone interview using the Telephone
Instrument for Cognitive Screening (TICS). Participants who
scored ≤ 30 screened positive for dementia and were referred
to a specialist at either St. Vincent Health or Community
Health Network for an evaluation and diagnostic assessment.
2.3. Statistical Analyses. Prior to conducting the analyses,
responses on the PRISM-PC questionnaire were reverse-
coded so that a higher score indicated stronger agreement on
the items. To facilitate interpretation of the domain scores, we
used a similar approach that is used to analyze scale scores on
the SF-36 [11]. We converted all domains to the same metric
by taking the sum of the reverse-coded responses and then
transforming the sum to a 0 to 100 scale by subtracting the
minimum possible score and dividing by the possible range.
For a given domain, this meant that 0 represented strongly
disagree on all items, 100 represented strongly agree on all
items, and 50 represented neutral scores on all items.
For comparisons of groups of participants, we used 𝑡 tests
if the variables were continuous and Fisher’s exact tests if the
variables were categorical. To model the association of the
PRISM-PC questionnaire domains with the dependent vari-
able (acceptance versus refusal of telephone screening with
the TICS), we used logistic regression and adjusted for covari-
ates found to be significant or marginally significant (𝑃 <
0.10) in bivariate analyses. We reported the results in terms
of odds ratios (ORs) and confidence intervals (CIs).
To determine if the scales derived from the phone admin-
istration of the PRISM-PC questionnaire showed the same
internal consistency from prior studies when the PRISM-
PC questionnaire was administered in person, we calculated
Cronbach’s alpha for each scale and compared it to previously
published PRSIM-PC questionnaire findings [12]. For all sta-
tistical analyses, we used SAS statistical software version 9.3
(SAS Institute Inc., Cary, North Carolina).
3. Results
Sociodemographic characteristics and participants’ experi-
ence with Alzheimer’s disease are presented by study site in
Table 1.There were no significant differences between the two
study sites regarding prior experience with Alzheimer’s dis-
ease. There were several significant differences between sites
in sociodemographic characteristics. Participants from St.
Vincent Health were significantly more likely to be married
(𝑃 < 0.05), have higher levels of education (𝑃 < 0.01), and
more likely to be African American (𝑃 < 0.001). Community
Health Network participants tended to be older (𝑃 = 0.05)
and more likely to live alone (𝑃 = 0.06).
Cronbach’s alphas for the PRISM-PC questionnaire
domain scales at the St. Vincent Health site were 0.85 for
benefits of dementia screening, 0.74 for stigma, 0.72 for loss of
independence, and 0.61 for suffering. Cronbach’s alphas for
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Table 1: Sociodemographic characteristics and experience with Alzheimer’s disease of study participants from St. Vincent Health and
Community Health Network.
St. Vincent Health
(𝑛 = 278)
%
Community Health
Network (𝑛 = 122)
%
𝑃 value
Age, years 0.051
65–69 32.3 20.5
70–74 20.6 22.1
75–79 20.6 19.7
≥80 26.5 37.7
Gender 0.172
Female 66.9 73.8
Race <0.001
White 78.1 96.7
African American 20.9 2.5
Other 1.1 0.8
Education, years 0.003
0–11 4.3 12.3
≥12 95.7 87.7
Housing status 0.063
Living alone 33.7 43.4
Living with someone 66.3 56.6
Marital status 0.030
Married 55.8 45.1
Widowed 28.3 43.4
Divorced 11.6 8.2
Never married 4.3 3.3
Income 0.124
<$10,000 4.1 5.1
$10,000–$19,999 17.3 20.4
$20,000–$39,999 28.4 38.8
≥$40,000 50.2 35.7
Do you have a relative or friend with Alzheimer’s
disease? 0.189
Yes 44.8 37.7
Do you believe that you are at higher risk of
Alzheimer’s disease than others of your same
age?
0.243
Yes 13.2 9.1
Do you think you have more memory problems
than others of your same age? 0.348
Yes 7.6 5.0
Has a doctor told you that you have memory
problems? 0.911
Yes 1.8 1.6
Are you taking medication to help with
memory? 0.733
Yes 2.2 1.6
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Table 2: Bivariate comparison of the sociodemographic characteristics and experience with Alzheimer’s disease of study participants who
accepted and refused screening for dementiaa at St. Vincent Health and Community Health Network.
St. Vincent Health (𝑛 = 278) Community Health Network (𝑛 = 122)
Number (%)
accepted
Number (%)
refused 𝑃 value
Number (%)
accepted
Number (%)
refused 𝑃 value
Overall 173 (62.2) 105 (37.8) 78 (63.9) 44 (36.1)
Age, years 0.780 0.071
65–69 55 (61.8) 34 (38.2) 19 (76.0) 6 (24.0)
70–74 39 (68.4) 18 (31.6) 18 (66.7) 9 (33.3)
75–79 34 (59.6) 23 (40.4) 16 (66.7) 8 (33.3)
≥80 45 (61.6) 28 (38.4) 25 (54.4) 21 (45.6)
Gender 0.844 0.292
Female 115 (61.8) 71 (38.2) 60 (66.7) 30 (33.3)
Male 58 (63.0) 34 (37.0) 18 (56.2) 14 (43.8)
Race 0.541 0.748
White 137 (63.1) 80 (36.9) 75 (63.6) 43 (36.4)
African American 35 (60.3) 23 (39.7) 2 (66.3) 1 (33.3)
Other 1 (33.3) 2 (66.7) 1 (100.0) 0 (0.0)
Education, years 0.007 0.814
0–11 3 (25.0) 9 (75.0) 10 (66.7) 5 (33.3)
≥12 170 (63.9) 96 (36.1) 68 (63.6) 39 (36.4)
Housing status 0.733 0.063
Living alone 57 (61.3) 36 (38.7) 29 (54.7) 24 (45.3)
Living with someone 116 (63.4) 67 (36.6) 49 (71.0) 20 (29.0)
Marital status 0.550 0.865
Married 98 (63.6) 56 (36.4) 37 (67.3) 18 (32.7)
Widowed 48 (61.5) 30 (38.5) 33 (62.3) 20 (37.7)
Divorced 17 (53.1) 15 (46.9) 6 (60.0) 4 (40.0)
Never married 9 (75.0) 3 (25.0) 2 (50.0) 2 (50.0)
Income (𝑁 = 465) 0.122 0.205
<$10,000 5 (62.5) 3 (37.5) 4 (80.0) 1 (20.0)
$10,000–$19,999 18 (52.9) 16 (47.1) 15 (75.0) 5 (25.0)
$20,000–$39,999 41 (73.2) 15 (26.8) 20 (52.6) 18 (47.4)
≥$40,000 73 (73.7) 26 (26.3) 25 (71.4) 10 (28.6)
Do you have a relative or friend
with Alzheimer’s disease? 0.003 0.074
No 83 (54.2) 70 (45.8) 44 (57.9) 32 (42.1)
Yes 89 (71.8) 35 (28.2) 34 (73.9) 12 (26.1)
Do you believe that you are at
higher risk of Alzheimer’s disease
than others of your same age?
0.106 0.511
No 144 (61.0) 92 (39.0) 69 (62.7) 41 (37.3)
Yes 27 (75.0) 9 (25.0) 8 (72.7) 3 (27.3)
Do you think you have more
memory problems than others of
your same age?
0.653 0.896
No 158 (61.7) 98 (38.3) 73 (64.0) 41 (36.0)
Yes 14 (66.7) 7 (33.3) 4 (66.7) 2 (33.3)
Has a doctor told you that you
have memory problems? 0.917 0.679
No 170 (62.3) 103 (37.7) 77 (64.2) 43 (35.8)
Yes 3 (60.0) 2 (40.0) 1 (50.0) 1 (50.0)
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Table 2: Continued.
St. Vincent Health (𝑛 = 278) Community Health Network (𝑛 = 122)
Number (%)
accepted
Number (%)
refused 𝑃 value
Number (%)
accepted
Number (%)
refused 𝑃 value
Are you taking medication to
help with memory? 0.821 0.679
No 169 (62.1) 103 (37.9) 77 (64.2) 43 (35.8)
Yes 4 (66.7) 2 (33.3) 1 (50.0) 1 (50.0)
aBecause our early work indicated that patients more readily understood the term “Alzheimer’s disease” than the term “dementia,” in this study we used
Alzheimer’s disease as a proxy for dementia.
Table 3: Bivariate comparison of the mean PRISM-PC questionnaire scores of study participants who accepted and refused screening for
dementia at St. Vincent (St. V.) Health and Community Health Network (Community).
Domains and individual itemsa
St. V. Health Community
Mean score (SD)
P Value
Mean score (SD)
P ValueAccepted
screening
(𝑛 = 173)
Refused screening
(𝑛 = 105)
Accepted
screening
(𝑛 = 78)
Refused screening
(𝑛 = 44)
Domain: benefits of dementia
screening 73.8 (10.1) 67.7 (13.3) <0.001 72.1 (9.5) 65.6 (12.8) 0.002
Domain: stigma of dementia
screening 32.0 (11.4) 33.3 (9.2) 0.323 33.7 (11.5) 34.9 (9.3) 0.545
Domain: negative impact of
dementia screening on
independence
50.6 (12.6) 53.3 (13.8) 0.086 50.8 (11.1) 49.1 (11.8) 0.444
Domain: suffering related to
dementia screening 59.0 (13.5) 58.6 (14.9) 0.828 59.1 (11.9) 53.0 (12.2) 0.009
Item in no domain: agreement
with screening for colon cancer 3.3 (1.0) 3.2 (1.0) 0.242 3.2 (1.1) 2.8 (1.0) 0.083
Item in no domain: agreement
with screening for depression 3.2 (1.0) 2.8 (1.0) 0.007 3.3 (1.0) 2.8 (1.0) 0.006
Item in no domain: belief that a
treatment for Alzheimer’s disease
is not currently available
2.6 (0.9) 2.7 (0.8) 0.281 2.5 (0.9) 2.7 (0.7) 0.217
PRISM-PC: Perceptions Regarding Investigational Screening for Memory in Primary Care.
aFor each domain, the table includes the individual item that was most relevant to our study objectives. The table also includes the 3 individual items that are
not covered under any domain.
the Community Health Network sample were 0.81 for bene-
fits, 0.78 for stigma, 0.78 for loss of independence, and 0.47 for
suffering.TheseCronbach alphas are comparable to or greater
than the Cronbach alphas calculated from similar samples
and in previously published PRISM-PC questionnaire studies
when patients completed the PRISM-PC questionnaire in
person and were asked to undergo dementia screening in
person [10, 12].
The associations of demographic characteristics and prior
AD experience with screening refusal are presented by site in
Table 2. Overall there were no significant differences between
dementia screening refusal at the two sites, 37.7% at St.
Vincent and 36.1% at Community (𝑃 = 0.746). The only
demographic variable significantly associated with screening
refusal at the St. Vincent Health site was education. At St.
Vincent Health only, participants with less than a high school
education were more likely to refuse screening than the
participants with at least a high school education. At both
sites, participants without a relative or friend with AD were
significantly more likely to refuse the screening (St. Vincent
Health 45.8% versus 28.2%; 𝑃 = 0.003 and Community
Health Network 42.1% versus 26.1%; 𝑃 = 0.074).
The association between screening refusal and the four
domains on the PRISM-PC questionnaire and on individual
questionnaire items are presented in Table 3. For both sites,
participants who refused screening had significantly lower
scores on the benefits domain than participantswho agreed to
screening. In addition, participants who refused screening at
both sites were less likely to agree to question on the PRISM-
PC questionnaire regarding annual screening for depression.
At the Community Health Network site, participants who
refused screening had significantly lower scores on the
suffering domain, meaning they were more likely to agree on
the items related to suffering as a result of screening for
dementia.
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Table 4: Logistic regression analysis of the odds of refusing to undergo screening for dementia at St. Vincent Health and Community Health
Network.
Variable
St. Vincent Health Community Health Network
Odds ratio
(95% confidence interval) P value
Odds ratioa
(95% confidence interval) P value
PRISM-PC questionnaire items
High domain score:
perception that dementia
screening is beneficial
0.80 (0.70, 0.91) 0.001 0.79 (0.63, 0.98) 0.029
High domain score: suffering
related to dementia screening 1.07 (0.97, 1.18) 0.200 0.89 (0.73, 1.08) 0.248
Perception that depression
screening is beneficial 0.80 (0.62, 1.04) 0.100 0.63 (0.40, 0.99) 0.049
Have a relative or friend with
AD 0.51 (0.30, 0.87) 0.014 0.43 (0.16, 1.12) 0.082
Lives alone 1.14 (0.64, 2.02) 0.662 2.18 (0.87, 5.44) 0.096
Education
(>high school+ versus 0–11
years) 0.19 (0.05, 0.82) 0.025 1.38 (0.36, 5.25) 0.640
Age, years 0.648 0.573
65–69 (reference group) 1.00 [reference] 1.00 [reference]
70–74 0.69 (0.32, 1.49) 1.71 (0.42, 6.93)
75–79 1.17 (0.56, 2.45) 1.02 (0.24, 4.74)
≥80 0.90 (0.44, 1.82) 2.01 (0.56, 7.25)
PRISM-PC, Perceptions Regarding Investigational Screening for Memory in Primary Care.
aOdds ratios report a 5-point difference in the scale score.
Results from the logistic regressions are presented in
Table 4. After adjusting for age and education, higher scores
on the items in the benefits domain were significantly asso-
ciated with decreased odds of refusing dementia screening
at both sites. Additionally, at both sites, respondents who
endorsed having a friend or relative with AD were less likely
to refuse screening (St. VincentHealthAOR=0.49;𝑃 = 0.009
and Community Health Network AOR = 0.39; 𝑃 = 0.052).
4. Discussion
In our study of primary care patients at two different Indi-
anapolis health care centers, we found that, despite different
sociodemographic characteristics, predictors of who accepts
and who declines dementia screening are similar. In this
study, where participants completed the PRISM-PC ques-
tionnaire and dementia screening by phone, perceptions
about the benefits of early identification remained a signifi-
cant predictor of screening acceptance as did having a friend
or relative with dementia. These results are consistent with
previous studies that have administered the PRISM-PC ques-
tionnaire in person and administered dementia screening in
person.
Findings form this study corroborate previous results that
have shown that people’s perceptions about the benefits of
dementia screening are associated with their willingness to
be screened. For example, the participants who had stronger
agreement on the statements regarding the benefits of know-
ing about dementia earlier (e.g., ability to plan for the future)
were more likely to accept screening. Of the various items of
sociodemographic data that were gathered for our study, only
level of education at the St. Vincent’s Health System site was
highly predictive of agreeing to be screened.The participants
from the St. Vincent’s Health System with less than a high
school education were more likely to refuse screening than
those with more than a high school education.
This study is the first to measure attitudes about demen-
tia screening with the PRISM-PC questionnaire and offer
screening by phone.The internal consistency reliability of the
domain scales as measured by Cohen’s Kappa was similar
to those obtained from face-to-face administration of the
PRISM-PC questionnaire and to those obtained in prior
studies. In our sample, more than half (63.7%) of older
primary care patients agreed to be screened for dementia by
phone following completion of the PRISM-PC questionnaire.
Despite the majority of participants agreeing, this rate is sig-
nificantly less than our previous work that has found rates of
people willing to be screened as high as 89.7% when we
approached in person and screened in person [10].
A limitation of this study is that we do not know if par-
ticipants had been screened for dementia as part of routine
care, prior to being recruited for this study. However, none
had a dementia diagnosis and less than 2% reported being
told by their physician that they had memory problems.
In summary, the PRISM-PC questionnaire instrument is
a valid tool to assess older primary care patients’ percep-
tions about dementia screening, even when administered by
phone. Across our work, in this study and others, belief in
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the benefits of recognizing dementia early is an important
predictor of patient behaviors regarding screening and could
be used in interventions designed to increase the uptake of
dementia screening.
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